Risperidone-Induced Polymenorrhea: An under Recognized Endocrine Adverse Reaction
Journal of Advanced Clinical Neurology Research · 2026-01-01 · 2 (1) · 1-4
DOI: 10.63721/26jacnr0107 ↗At a glance
Journal article in Journal of Advanced Clinical Neurology Research, published online on 2026-01-01. Written by Neena Bhatti.
Abstract (original language)
Background
Antipsychotic medications, particularly risperidone, are widely used in the management of psychotic disorders due to their efficacy and favorable side effect profile compared to typical antipsychotics. However, endocrine and reproductive adverse effects such as hyperprolactinemia are increasingly recognized, yet often underdiagnosed. Methodology: The Department of Pharmacology, CMC Ludhiana, is an ADR reporting centre. The case was reported to ADR Centre from the Psychiatry Ward as a part of Pharmacovigilance Elective in MBBS Third Prof Part-1.
Conclusion
Polymenorrhea is a rare but significant adverse effect of risperidone that may impair quality of life and treatment adherence. Routine surveillance and early recognition of endocrine side effects, coupled with interdisciplinary management, are essential for optimizing patient care in psychiatric settings.
Cite
APA
Bhatti, N. (2026). Risperidone-Induced Polymenorrhea: An under Recognized Endocrine Adverse Reaction. Journal of Advanced Clinical Neurology Research, 2(1), 1-4. https://doi.org/10.63721/26jacnr0107
Vancouver
Bhatti N. Risperidone-Induced Polymenorrhea: An under Recognized Endocrine Adverse Reaction. Journal of Advanced Clinical Neurology Research. 2026;2(1):1-4. doi:10.63721/26jacnr0107
BibTeX
@article{Bhatti2026,
author = {Bhatti, Neena},
title = {Risperidone-Induced Polymenorrhea: An under Recognized Endocrine Adverse Reaction},
journal = {Journal of Advanced Clinical Neurology Research},
year = {2026},
volume = {2},
number = {1},
pages = {1--4},
doi = {10.63721/26jacnr0107}
}
EUVIMED